This Microcap Just Proved Its First Profitable Quarter Wasn't a Fluke

Sponsored:

Tuesday, August 11, 2026

State and county health agencies are being asked to do more with flat budgets, and the vendors serving them are stuck choosing between chasing volume and protecting margin. For small-cap healthcare services firms, that pressure usually shows up as revenue growth with nothing left at the bottom. The rarer outcome is a contractor that grows the top line and widens margins at the same time, the mark of a durable business rather than one simply booking work.

Shares of Syra Health Corp. (OTCQB: SYRA) are gaining Tuesday after the integrated healthcare solutions company posted 23% revenue growth and its second consecutive profitable quarter, following its first profitable quarter ever in Q1. Q2 revenue reached $2.4 million, up from $1.9 million a year earlier, and net income came in at $250,242 against a $63,596 loss in Q2 2025, a swing of roughly $314,000.

The improvement carried through the rest of the income statement. Earnings per share rose to $0.02 from a $0.01 loss, and EBITDA moved from a $53,760 loss to positive $253,200. Through six months, Syra Health earned $491,221 compared with a $535,861 loss over the same stretch of 2025.

Margins did the heavy lifting. Revenue outpaced cost growth in the quarter, lifting gross margin 580 basis points to 44.5% from 38.7%, the highest quarterly gross margin in company history. Revenue mix and operating leverage drove the expansion.

Both revenue lines contributed. Population health solutions, the higher-margin side of the business, grew 8% to $1.72 million, while healthcare workforce revenue jumped 87% to $678,113 as staffing demand climbed and the company steered toward better-margin contracts. Total operating expenses held essentially flat year over year at $814,732.

Cash generation improved as well. Operating activities produced $643,183 through six months versus $85,754 a year earlier. Syra Health closed the quarter with $2.1 million in cash and no long-term debt, down from $2.9 million at March 31 as receivables grew $552,000 and deferred revenue billed during the first quarter was recognized.

Recent contract activity supports the outlook. Syra Health picked up one-year renewals with Wake County Public Health in North Carolina and the Indiana Veterans' Home, plus an amendment to its Indiana FSSA contract that extends a learning management platform to the state's Bureau of Disability Services through October 2028. Approval of the CMS ACCESS Model, in partnership with HealthSync, is anticipated in the near term and is expected to be a durable revenue source for the next 10 years.

The company continues to target full-year profitability for 2026, with revenue recognition and contract timing likely to keep quarterly results uneven.

Shares of SYRA are up 11.3% to $0.74 in Tuesday morning trading.

Sponsored: